This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Apple's iPad Tops With Doctors

Stocks in this article: AAPLRIMM




By Bertha Coombs, CNBC Reporter

NEW YORK ( CNBC) -- There are two things Dr. Larry Nathanson can't work without when he's on duty in the emergency ward: his stethoscope and his iPad.

After nearly a year using the tablet, it has become an integral tool for treating patients.

"As I am walking from room to room, I know who I need to see next," he explained, scrolling through the virtual emergency room patient board on the iPad.

"I definitely feel lost when I don't have this on a shift," he said.

More from CNBC
How iPhone Led to AT&T Merger
Cramer: This Is 'Most Exciting' Stock in the Dow
Tiger Woods Talks About His New Golf Swing App

As the director of emergency medicine at Boston's Beth Israel Deaconess Medical Center, Nathanson was among the first doctors at the hospital to buy an iPad the day it launched. He paid for it himself, but it has more than paid off in the time he saves not having to chase down records.

"Patients often have a lot of questions, and I am able to answer them immediately with the latest data in real time," Nathanson said. "I can sit there at the bedside and I can go over what's going on."

When it comes to treating surgical patients, being able to pull up diagrams and x-rays at their bedside has been a real game changer for B.I. Deaconess Dr. Henry Feldman.

"The number of times I've had patients say to me 'That's the first time I've understood my disease' -- I mean, it happens all the time to me. To me, that's validation as a doctor," he said.

Some also see doctors' embrace of the iPad as validation for Apple (AAPL) as a new leader in the health-care enterprise market, while competitors like Research in Motion (RIMM) are just beginning to roll out their tablets.

Analysts at Chilmark Research estimate 22 percent of doctors in the U.S. were using iPads by the end of 2010. In February, four out of five doctors surveyed by health marketing company Aptilon said they planned to buy an iPad this year.

The strength of doctors' iPad adoption has caught the health care IT industry by surprise.

"It's created quite a disruption for the health care IT vendors," Chilmark health-care IT analyst John Moore said. "It's very challenging as to how to prioritize this."

It comes at a time when the industry has been focused on rolling out updated electronic health record systems that will help hospitals and doctors meet deadlines for achieving federal health care technology standards known as "meaningful use."

Yet, in many ways, that's what may be helping to drive the intensity of doctor demand for the iPad.

The Perfect Storm

The government authorized up to $30 billion in reimbursements for qualifying health care IT systems as part of the 2009 stimulus act, in an effort to speed up adoption of electronic health records, known as EHRs.

The criteria for meaningful use in 2011 include capturing patient information in EHRs and inputting more of doctors' treatment orders and prescriptions electronically. The goal is to improve care by reducing errors and duplication, ultimately bringing down costs.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,069.71 +95.40 0.56%
S&P 500 0.00 -2.75 -0.14%
NASDAQ 4,532.1990 -17.0270 -0.37%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs